healthtech startup that seeks to manage and reverse type 2 and pre-diabetes, on Tuesday said it has raised $11 million in a Series A funding round led by MassMutual Ventures.
Other participating investors include Cure.fit, Tanglin Venture Partners, and Endiya Partners. The fresh capital will be used to expand Sugar.fit’s product offering, launch an offline presence, and accelerate research and development in the field of diabetes management, as per a statement from the company.
An estimated 100 million individuals struggle with Type 2 diabetes, and another 130 million are on the brink of pre-diabetes, the statement added. Sugar.fit offers a diabetes care programme, integrating devices such as continuous glucose monitors, fitness trackers and other health diagnostics. It also provides access to diabetes specialists and health coaches.
Users use Sugar.fit’s platform to track the real-time impact of their lifestyle on glucose levels, and receive personalised guidance across the aspects of fitness, nutrition and sleep. These users have seen an average 2% reduction in HbA1c levels after 3 months, the statement added. HbA1c refers to a test that shows the average blood sugar level of a person over two to three months.
“This investment will enable us to enhance our technology and expand our reach across India, ultimately helping more people take control of their diabetes and improve their health,” said Madan Somasundaram, co-founder and